NASDAQ:BNTC - Benitec Biopharma Limited
$1.74
 $-0.06
-3.30%
1:35PM EDT
2019-02-15
Benitec Biopharma Limited is a biotechnology company. The Company is engaged in progressing programs through the clinic; the commercialization of its Intellectual Property (IP); development of its therapeutic pipeline and pre-clinical programs, and funding, and protecting and building the IP estate. Its In-house product candidates include TT-034, BB-HB-331, BB-AMD-211 and ddRNAi therapeutic. It is focused on commercialization by licensing and partnering of patents and licenses in biotechnology, in functional genomics, with applications in biomedical research and human therapeutics. It has a pipeline of in-house and partnered therapeutic programs based on its patented gene-silencing technology, deoxyribonucleic acid (DNA)-directed ribonucleic acid interference (ddRNAi). The Company is engaged in developing treatments for chronic human conditions, such as hepatitis B, wet age-related macular degeneration (AMD), and oculopharyngeal muscular dystrophy (OPMD) based on this technology. Read more at  reuters.com
sector:  health care
industry:  biotechnology
the data below are updated and published after 9pm EDT each trading day
  BNTC     avg for
industry  
  avg for
sector  
42 stocks weight:  9. 15   0. 00   0. 00  
42 stocks rank:  3. 93 K 1. 86 K 1. 09 K
# analyst opinions:  1. 00   14. 92   14. 43  
mean recommendation:  3. 00   1. 91   1. 93  

quick ratio:  8. 00   5. 37   1. 81  
current ratio:  8. 20   5. 69   2. 19  

target price low:  1. 40   88. 97   117. 82  
target price avg:  1. 40   115. 19   141. 96  
target price high:  1. 40   143. 40   163. 16  
1-yr high:  3. 60   124. 30   142. 77  
last close:  1. 84   101. 85   127. 84  
50-day avg:  1. 57   98. 27   122. 46  
200-day avg:  2. 28   99. 72   122. 70  
1-yr low:  1. 14   78. 19   100. 16  
volume:  162. 00   2. 38 M 4. 64 M
50-day avg volume:  7. 53 K 3. 31 M 4. 94 M
200-day avg volume:  34. 15 K 3. 23 M 4. 28 M

1-day return:  2. 22 % 0. 22 % 0. 48 %
this week return:  32. 37 % 1. 77 % 2. 01 %
12-wk return:  -24. 28 % 6. 56 % 3. 33 %
52-wk return:  -57. 53 % -2. 23 % 14. 35 %

enterprise value (EV):  18. 63 M 55. 17 B 104. 51 B
market cap:  23. 58 M 49. 01 B 96. 46 B

shares outstanding:  257. 03 M 607. 99 M 1. 22 B
shares:  7. 68 M 605. 53 M 1. 15 B
shares short:  10. 67 K 11. 62 M 12. 55 M
shares short prior month:  13. 54 K 11. 95 M 13. 44 M
short ratio:  1. 03   4. 82   3. 10  

book value:  1. 08   14. 43   28. 26  
price/book:  1. 70   -1. 57   -2. 97  
gross profits:  4. 17 M 8. 28 B 18. 09 B
operating margins:  0. 00 % -458. 01 % -642. 83 %
EBITDA margins:  -247. 77 % 13. 81 % 22. 47 %
profit margins:  -251. 95 % 6. 57 % 9. 92 %
gross margins:  90. 24 % 49. 33 % 54. 53 %

1-yr max volatility:  51. 93 % --- ---
1-yr mean volatility:  -0. 11 % 0. 01 % 0. 06 %

1-yr EPS:  -0. 82   3. 03   4. 09  
forward EPS:  -0. 24   4. 33   6. 99  
P/E:  -2. 24   6. 11   26. 91  
forward P/E:  -6. 00   8. 38   10. 48  
PE/G:  0. 15   0. 37   5. 61  
growth:  -15. 20 % 683. 72 % 104. 79 %
earnings high:  -0. 00   1. 27   1. 66  
earnings avg:  -0. 00   1. 01   1. 53  
earnings low:  -0. 00   0. 76   1. 40  
revenue high:  -0. 00   2. 86 B 11. 19 B
revenue avg:  -0. 00   2. 78 B 10. 84 B
revenue low:  -0. 00   2. 67 B 10. 64 B
return on assets:  -33. 07 % -3. 27 % 3. 81 %
return on equity:  -57. 84 % 107. 48 % 27. 82 %
revenue growth:  -15. 20 % 648. 36 % 97. 70 %

beta (1yr vs S&P500):  0. 32   1. 21   0. 93  
sharpe (1yr):  -0. 29   0. 06   0. 98  

held % insiders:  0. 00 % 6. 46 % 3. 21 %
held % institutions:  4. 00 % 79. 10 % 70. 01 %

Research more with google or yahoo!
the data below are updated and published after 9pm EDT each trading day

2019-02-14 : BNTC
.    + 0.536 =         0.536 :: INITIAL WEIGHT
.  + 410.436 =       410.972 :: inverse volume-to-price addition
.    + 0.013 =       410.985 :: spline projection addition
.   - 169.62 =       241.365 :: poor performance penalty
.    x 0.715 =        172.54 :: one-year gains+dividend factor
.   x 10.448 =      1802.757 :: 13 weeks' performance factor
.    x 1.492 =      2690.594 :: industry recommendation factor
.    x 1.142 =      3071.563 :: symbol recommendation factor
.    x 0.997 =      3061.406 :: return on assets factor
.    x 0.994 =      3043.699 :: return on equity factor
.    x 0.998 =      3039.073 :: revenue growth factor
.    x 2.559 =      7777.216 :: current ratio factor
.    x 1.069 =      8314.342 :: quick ratio factor
.    x 1.404 =     11672.322 :: short ratio factor
.    x 2.017 =     23543.506 :: price-to-book factor
.    x 1.034 =     24346.368 :: 5-day avg > 50-day avg
.    x 2.163 =     52658.513 :: P/E weight
.    x 1.613 =     84952.957 :: PE/G factor
.    x 1.556 =     132188.77 :: beta factor
.    x 0.293 =     38690.006 :: sharpe factor
.    x 0.951 =     36798.028 :: target low factor
.    x 0.913 =     33608.569 :: target mean factor
.    x 0.951 =     31965.078 :: target high factor
.    x 1.066 =     34062.396 :: industry 12-weeks return
.    x 0.931 =     31713.156 :: "drift" penalty 1 days ago
.    x 0.813 =     25792.428 :: "drift" penalty 3 days ago
.    x 0.969 =     24986.824 :: "drift" penalty 4 days ago
.    x 0.978 =     24444.353 :: overall "drift" factor
.    x 0.481 =     11751.027 :: largest single-day jump factor
.    x 0.065 =       766.038 :: low price factor
.      x 1.0 =        766.09 :: factor hist industry gain for week 06
.   cubeRoot =          9.15 :: reduced for readability
.                       9.15 :: FINAL WEIGHT for NASDAQ:BNTC


 


News feed RSS items generated from finance.google.com

News feed formatting by feed2js.org